TTN

Clinical trial pipeline · Data from ClinicalTrials.gov

See which TTN trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07332013

Urinary Titin Biomarker in DMD

A universal challenge in clinical investigation of novel therapeutics is the need for quantitative, objective biomarkers that directly address the mechanisms of…

United States50 participantsStarted 2026-03-04

Treatment: Descending stair walk

RecruitingNot Applicable

NCT01403402

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

The Congenital Muscle Disease Patient and Proxy Reported Outcome Study (CMDPROS) is a longitudinal 10 year study to identify and trend care parameters, adverse…

United States4,000 participantsStarted 2009-09

All recent trials (20 shown)

Not Yet RecruitingNot Applicable

NCT07350421

The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN)

TTN is the most common respiratory disorder in the perinatal period, causing 40% of cases of respiratory distress after birth. Lung fluid absorption is initiate…

Syria1 participantsStarted 2026-01-01

Treatment: Salbutamol (Albuterol), Normal Saline

Active — Not RecruitingPhase 3

NCT05527704

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)

Clinical trial evaluating the efficacy and safety of salbutamol for the treatment of neonates with a gestational age between 32 and 42 weeks with transient tach…

Poland608 participantsStarted 2021-12-31

Treatment: Salbutamol, 0,9% Chloride Sodium

TTN

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Urinary Titin Biomarker in DMD

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

All recent trials (20 shown)

The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN)

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Urinary Titin Biomarker in DMD

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

All recent trials (20 shown)

The Effectiveness of Inhaled Salbutamol in the Management of Transient Tachypnea of the Newborn(TTN)

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)

Comparison of Congenital Pneumonia and Transient Tachypnea of the Newborn

Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other C…

Role of Salbutamol in the Management of Transient Tachypnea of the New Born

The Validity of Urinary Titin and Skeletal Muscle Index as Predictor of Muscle Weakness in Critically Ill Patients. A Pr…

Use of Gentle Synchronized Negative Pressure in Helping Babies Breathe

Moderate Intensity Training in Patients With Truncating Genetic Variants in TTN.

Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates

Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)

Effect of Cannula Size on Oxygen Saturation During Nasal High Flow Therapy in Newborns

Measuring Serum Level of Total L Carnitine in HIE and TTN

Role of Salbutamol and Furosemide in TTN

Thermal Imaging in Neonates: A Feasibility Study in Healthy Babies and Babies With Suspected TTN

PATET Ratio to Rule Out Transient Tachypnea of the Newborn

Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neona…

Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Ne…

Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn